Dr Reddys Laboratories is recalling about 58,656 bottles of the heartburn drug lansoprazole in the US due to a microbial contamination, according to reports.
Report said that this move comes amid a string of quality problems for Indian drugmakers.While product recalls are not uncommon, the FDA announcement comes amid a string of quality problems for Indian drugmakers. Earlier report said that US regulator also announced it was banning imports from Sun Pharmaceutical Industries Ltd, Karkhadi manufacturing plant in the western state of Gujarat.
Dr Reddy's voluntary recall of lansoprazole delayed release capsules, a generic version of Swiss drugmaker Novartis' drug Prevacid 24 HR, began on January 3, 2014.
Previous this week, Sun Pharma had voluntarily recalled 2,528 bottles of its generic version of diabetes drug Glumetza in the US market on the basis of a customer complaint. Among others, some plants of Ranbaxy and Wockhardt have already been banned from importing drugs into the US market.
Whereas all plants of Daiichi Sankyo controlled Ranbaxy Laboratories in India have been banned from exporting drugs to the US, Wockhardt has also faced similar actions on its two plants in the country. Dr Reddy's Laboratories shares today closed at Rs 2,734.15 on the BSE, up 1.63 percent from its previous close.